| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | E1IO3ICJ9A |
| InChI Key | UXXQOJXBIDBUAC-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C31H42N6O4 |
| Molecular Weight | 562.72 |
| AlogP | 5.03 |
| Hydrogen Bond Acceptor | 8.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 10.0 |
| Polar Surface Area | 92.29 |
| Molecular species | BASE |
| Aromatic Rings | 3.0 |
| Heavy Atoms | 41.0 |
| Primary Target | |
|---|---|
| fms related receptor tyrosine kinase 3 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Renal Cell | 2 | D002292 | ClinicalTrials |
| Gliosarcoma | 2 | D018316 | ClinicalTrials |
| Oligodendroglioma | 2 | D009837 | ClinicalTrials |
| Astrocytoma | 2 | D001254 | ClinicalTrials |
| Oligodendroglioma | 2 | D009837 | ClinicalTrials |
| Myelodysplastic Syndromes | 1 | D009190 | ClinicalTrials |
| Leukemia, Myeloid, Acute | 1 | D015470 | ClinicalTrials |
| Glioblastoma | 1 | D005909 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 387867-13-2 |
| ChEBI | 90237 |
| ChEMBL | CHEMBL124660 |
| DrugBank | DB05465 |
| EPA CompTox | DTXSID8048947 |
| FDA SRS | E1IO3ICJ9A |
| Guide to Pharmacology | 5695 |
| PubChem | 3038522 |
| SureChEMBL | SCHEMBL927974 |
| ZINC | ZINC000003966243 |